Detecting kidney DNA in transplant patients' blood
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study looks for small pieces of kidney DNA in the blood of kidney transplant patients. It aims to improve monitoring of transplant health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have end-stage kidney failure (your kidneys no longer work well enough to keep you alive without treatment).
- You are scheduled to receive a kidney transplant at Pitié Salpêtrière Hospital.
- You have been told about the study and agree not to object to it, and you have signed a consent form for the genetic testing.
- You have health insurance through the French social security system (not AME).
- You are not under legal protection like a guardianship or curatorship.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing whether a simple blood test that looks for donor DNA can help doctors take better care of kidney transplant patients. It may help detect early signs of rejection and guide treatment decisions.
This trial looks at ways to predict how kidney disease may develop, change, or cause complications using information from patients. It may help doctors identify people at higher risk and tailor care earlier.
This study looks for pieces of kidney DNA in the blood of people who have a kidney transplant and need a biopsy. The goal is to see if this test can help doctors know if the kidney is being rejected without needing a biopsy.
This study will collect blood samples from people having a kidney biopsy or a kidney transplant to look for biomarkers (biological signs) that can give doctors more information about kidney health. Participating may help doctors better understand and treat kidney disease in the future.
This study looks at how genes in the kidney change when the body might be rejecting the transplant. By studying these genes, doctors hope to find better ways to detect kidney rejection early and help keep the kidney healthy longer.
This study is testing a new way to monitor kids who have had a kidney transplant, without using needles as often. The goal is to adjust anti-rejection medicines more precisely for each child, which could help the kidney last longer and reduce side effects.
Hear when a new Acute Kidney Injury trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.